Dr. Liangliang Hao
Principal Investigator
Assistant Professor, Department of Biomedical Engineering
-
Postdoc. Massachusetts Institute of Technology
Ph.D. Northwestern University
-
Honors and Awards
NIH-NCI Pathway to Independence Award (K99/R00)
American Cancer Society Postdoctoral Fellowship Award
Ludwig Molecular Oncology Postdoctoral Fellowship
Howard Hughes Medical Institute International Student Research Fellowship
International Institute for Nanotechnology Outstanding Research Award
Oligonucleotide Therapeutics Society Nucleic Acid Research Award
Leading Edge Fellow, Inaugural HHMI Leading Edge Symposium
Bayer Lindau Fellow, Bayer Science & Education Foundation
Convergence Scholar, MIT Marble Center for Cancer Nanomedicine
Post-doc Associates
-
I am interested in developing delivery systems of biologics (especially nucleic acids), to realize translational precise theragnostics. I am also interested in merging data science and AI with therapeutics in my future work.
LinkedIn
Education:
PhD in Pharmaceutics and Pharmaceutical Chemistry at University of Utah 2017-2022
Master in Pharmaceutics at Peking University, China 2014-2016
Bachelor in Pharmaceutical Science at Peking University, China, 2010-2014
-
I am interested in developing innovative tools for non-invasive disease early detection, risk stratification and treatment monitoring. I’m also interested in exploring approaches for disease biomarkers profiling.
Education:
PhD in Pharmaceutics at Peking University, China, 2019-2024
BS in Pharmaceutical Science at Peking University, China, 2015-2019
-
I am interested in developing point-of-care technologies for rapid and accessible molecular diagnostics. My previous work focused on applying nucleic acid amplification techniques to diverse diagnostic applications, and at the Hao Lab, I aim to build on this background to develop non-invasive and portable platforms that support the lab’s vision for precision molecular diagnostics.
Education:
PhD in Bioengineering and Biomedical Engineering – Purdue University 2019 - 2024
BS in Controlled Environment Agriculture Science & Engineering – China Agricultural University 2015 - 2019
PhD Students
-
I am interested in enhancing clinical usefulness of therapeutics through improving tissue targeting and reducing off-site toxicity. In the lab, I seek to engineer nanoscale delivery systems to precisely treat and sense tumors.
Honors & Awards: SB2 Trainee
Education: BS & MS in Biomedical Engineering at Case Western Reserve University 2018-2022
-
I am particularly interested in researching women's health and developing medical diagnostics and tools that can help treat women and underrepresented minorities in the health industry. In addition to women's health, I am also driven to create medical tools that can be used in low-resource settings.
Honors & Awards: Biofeedback Control Trainee
Education: BS in Biomedical Engineering at UC Davis 2020-2024
-
I’m working on establishing a high-throughput approach to assess protease activity in a spatial context in order to better inform the development of diagnostics and therapeutics that leverage the activity of endogenous proteases. I am also interested in creating novel point-of-care diagnostics.
Honors & Awards: Salisbury Prize
Education: BS Biology & Biotechnology Worcester Polytechnic Institute 2014-2018
-
I am interested in leveraging synthetic biology tools to improve cancer diagnostics and therapeutics. My current work includes characterizing the protease activity profile of colorectal cancer for T cell engager design; engineering logic-gated receptors that are activated conditionally within the tumor microenvironment; and developing a toehold switch-based system that produces volatile compounds upon tumor sensing.
Education: BS in Biological Engineering at Johns Hopkins University, 2021-2024
-
My primary research interest lies in leveraging multi-omics data to gain a more comprehensive understanding of the molecular mechanisms underlying cancer development and progression, as well as translating the insights into clinically diagnostics and treatments. I am also working on engineering CRISPR tools for rapid, stable, and low-cost diagnostics that could be deployed in point-of-care settings.
Education: Bachelor in Pharmaceutical Engineering at Tianjin University, 2015-2019
MS in Bioengineering at Northeastern University, 2019-2021
-
I am developing yeast-based selection methods for improving protease and nanobody specificity toward therapeutic targets. I aim to integrate laboratory evolution and scalable screening methods to rapidly, and cost-effectively produce bespoke therapeutics. (*Co-advised with Mo Khalil)
Honors & Awards: William D. Larson Scholarship
Education: BS in Chemistry, Minor in Biology, University of St. Thomas, MN 2016-2020
MS Students
-
My interests center on nanobody-based targeting strategies to enhance specificity in tumor-associated environments and enable clinically meaningful diagnostic and therapeutic applications.
Education:
B.S in Biomedical Engineering -California State University 2020-2024
-
I'm interested in developing 3D cancer diagnostic platforms using spheroids and organoids to detect tumor-specific biochemical activity while preserving spatial information. I'm also interested in scalable organ-on-chip approaches for point of care diagnostics in resource limited settings.
Education:
B.S in Biomedical Engineering – Boston University 2021 - 2025
LinkedIn
Lab Alumni
Xingxiao (Carrie) Li
Undergraduate Researcher 2023-2024
Xiaolei (Linda) Song
Undergraduate Researcher
2023-2025
Aidan Holmes
Undergraduate Researcher 2023-2025
Jocelyn Zhu
Master’s Researcher - Project
2023-2025
Matthew Chen
Undergraduate Researcher 2024-2026
Nina Kniska
Undergraduate Researcher 2026